Fake Certification: Plant Trying To Export Antibiotics Raided

Ahmedabad : On Thursday, Gujarat’s food and drugs authority raided a pharmaceutical plant in Hajipur, in Kalol taluka of Gandhinagar district, that was packing antibiotics to Nigeria, based on a fake certification, said food and drugs commissioner H G Koshia. He added that the raw material seized from the location has been sent for laboratory tests.

“We have seized raw material and packaging items worth Rs 63 lakh. The alleged factory, Sunlovis Pharmaceutical LLP, Ahmedabad, was allegedly packing antibiotic drug called “Exaclav-625 Co-Amoxiclav Tablet BP” and was using an alleged fake certification of Ms Finecure Pharma, a company based in Uttrakhand, Koshia said.

“What has intrigued us was that the cartons and other packaging material had printed on them that the drug was manufactured by Nicholson Healthcare and was marketed by Exagon Pharmaceuticals located in Abuja in Nigeria. We are investigating whether these spurious antibiotic drugs were pumped into the Indian market as well,” Koshia added.

The carton also claimed that the drug was manufactured under licence from Brussels Laboratories Pvt Ltd. “Sunlovis also manufactured another drug for which they had no approval for, called Exatil,” Koshia said.

He said that the company was functional for last three years. “The extent of the scam is being analysed by a team of Gujarat FDCA. The owner of the alleged firm Pravin Chaudhary is being questioned, which will help us understand its extent,” added Koshia. A senior FDCA official revealed that all the cartons had manufacturing date as January.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’